Skip to content

Clinical trials

Phase 2 Diabetic Nephropathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Nephropathies Phase: Phase 2 Clear all

109 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20041
20052
20065
20073
20083
20096
20106
20118
20127
20135
20143
20155
20161
20171
20185
20195
20206
20215
20227
20238
20245
20256
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed76
Recruiting9
Terminated8
Unknown status5
Active, not recruiting4
Withdrawn4
Not yet recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie (prior sponsor, Abbott)4
AstraZeneca4
Bayer4
Tanabe Pharma Corporation4
Biogen3
Novartis Pharmaceuticals3
Pfizer3
University of Colorado, Denver3
University of Washington3
Ain Shams University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Nephropathies109
Diabetes Mellitus, Type 223
Renal Insufficiency, Chronic21
Diabetes Mellitus16
Proteinuria11
Kidney Diseases10
Albuminuria9
Diabetes Mellitus, Type 18
Hypertension7
Diabetes Complications5

Trials

Showing 1 to 25 of 109. Each trial links to its page on Pharma Observatory.

9 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.